Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries
About the Authors.
Part One The Life Science Industry Context for Portfolio, Program, and Project Management.
1 A Review of Project Management in Life Science Industry Sectors (Thomas R. Dunson).
2 The Impact of Organizational Size on Drug Project Management (Eric Morfin).
3 Drug Development in Biotechnology and How We Can Do It Better (Susan Linna).
Part Two The Portfolio, Program, and Project Management Approaches and Processes.
4 An Overview of the Organization and Processes of Portfolio, Program, and Project Management (Pete Harpum).
5 Portfolio Management in the Pharmaceutical Industry: Balancing Corporate Need with the Reality of Delivering Products to the Market (John Bennett).
6 Program Management in Drug Development (Pauline Stewart-Long).
7 Project Control (Martin Powell).
8 Managing Uncertainty in Drug Projects (Pete Harpum and Thomas R. Dunson).
9 Managing Drug Safety Risk (Thomas R. Dunson and Eric Morfin).
10 Developing Program Strategy (Pete Harpum).
11 Developing Products with "Added Value" (Trevor J. Brown and Stephen Allport).
Part Three Integrating the Processes.
12 Integrated Business Processes to Support Cross-Functional Drug Development (Martin D. Hynes III).
13 Integrated Drug Development From Cradle to Grave and From Lab to Market (Stephen Allport and Terry Cook-Davies).
14 The Development of P3M Capability in Drug Development Organizations (John Arrowsmith, Patrick Grogan and Bob Moore).
15 Implementing Portfolio, Program, and Project Management Best Practices in Drug Development Organizations (Pete Harpum, Ashley Jamieson and Inge Fisher).
Portfolio, Program, and Project Management in the Pharmaceutical and Biotechnology Industries (US $116.00)
Total List Price: US $214.95
Discounted Price: US $161.21 (Save: US $53.74)